摘要
目的分析局部晚期宫颈癌(LACC)组织中Ki-67、P糖蛋白(P-gp)的表达与新辅助化疗(NACT)疗效的关系,探讨二者的共表达性及临床病理意义。方法运用免疫组化法对53例LACC患者进行NACT前Ki-67、P-gp的表达量进行检测。结果53例LACC患者中有效32例(60.4%)。NACT疗效与Ki-67、P—gp的表达显著相关(P=0.006、0.029),Logistic回归显示Ki-67表达量越高、P—gp表达量越低,NACT越敏感(B=2.163、-3.39)。Spearman分析显示尚不能认为Ki-67与P—gp相关(P=0.325),且尚不能认为二者的共表达性与深肌层浸润、盆腔淋巴结转移相关(P=0.242、0.871)。结论NACT可用于LACC的治疗,Ki-67、P-gp可作为预测NACT疗效的指标。
Objective To study the correlation between expression of Ki-67, P-gp and effect of neoadjuvant chemotherapy(NACT) in locally advanced cervical cancer(LACC), and to investigate coexpression of Ki-67, P-gp and its siginificance. Methods Fifty-three cases of LACC biopsy specimens before treatment were collected. Expression of Ki-67 and P-gp was analyzed with the technique of immu- nohistochemical staining. Results Thirty-two cases were effective among the total cases(60. 4% ). There was siginificant correlation of the expression of Ki-67, p-gp with the effect of NACT (P = 0. 006, 0. 029). High expression of Ki-67 and low expression of P-gp were positive factors for effect of NACT through results of the logistic regression ( β = 2. 163, - 3.39 ). The results of the spearman corelations showed that there was no correlation of the expression of Ki-67 with P-gp(p =0. 325). Co-expression of Ki-67, P-gp showed no relationship with deep stromal invasion and pelvic lymph node metastasis (p = 0. 242, 0. 871 ). Conclusions NACT can be applied to treatment of LACC, and the expression of Ki-67 and P-gp are indicators of predicting the effect of NACT.
出处
《中国实用医刊》
2015年第8期1-4,共4页
Chinese Journal of Practical Medicine
基金
河南省医学科技攻关计划项目(豫卫科[2010]17号)